Literature DB >> 12516062

Clinical consequences of hepatitis C virus infection.

F Zoulim1, M Chevallier, M Maynard, C Trepo.   

Abstract

Hepatitis C virus (HCV) is a positive strand RNA virus that belongs to the Hepacivirinae genus within the Flaviviridae family. HCV infection has a wide spectrum of cellular tropism and clinical presentations. This has major impacts in terms of pathogenesis and diagnosis. Consequently, a wide range of clinical consequences characterises this viral infection, including asymptomatic chronic carriage, acute hepatitis, chronic hepatitis, cirrhosis, hepatocellular carcinoma and extrahepatic manifestations. The latter are commonly observed and may represent the first sign of the disease. A better knowledge of the pathobiology of HCV and its clinical consequences will be important for developing better treatment strategies to cure HCV infection and extrahepatic manifestations. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12516062     DOI: 10.1002/rmv.371

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  34 in total

1.  The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models.

Authors:  Yongshui Fu; Wenjie Xia; Yizhong Wang; Linwei Tian; Oliver G Pybus; Ling Lu; Kenrad Nelson
Journal:  Transfusion       Date:  2010-04-23       Impact factor: 3.157

2.  The full-length genome sequences of nine HCV genotype 4 variants representing a new subtype 4s and eight unclassified lineages.

Authors:  Ling Lu; Yan Xu; Jie Yuan; Chunhua Li; Donald G Murphy
Journal:  Virology       Date:  2015-04-05       Impact factor: 3.616

3.  The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.

Authors:  William J Towner; Lanfang Xu; Wendy A Leyden; Michael A Horberg; Chun R Chao; Beth Tang; Daniel B Klein; Leo B Hurley; Charles P Quesenberry; Michael J Silverberg
Journal:  J Acquir Immune Defic Syndr       Date:  2012-07-01       Impact factor: 3.731

4.  Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.

Authors:  Tetsuro Suzuki; Kazuhiko Omata; Tazuko Satoh; Takahiro Miyasaka; Chiaki Arai; Munehiro Maeda; Tomonori Matsuno; Tatsuo Miyamura
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e.

Authors:  Chunhua Li; Ling Lu; Donald G Murphy; Francesco Negro; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2014-05-02       Impact factor: 3.891

Review 6.  Boron chemicals in diagnosis and therapeutics.

Authors:  Bhaskar C Das; Pritam Thapa; Radha Karki; Caroline Schinke; Sasmita Das; Suman Kambhampati; Sushanta K Banerjee; Peter Van Veldhuizen; Amit Verma; Louis M Weiss; Todd Evans
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

7.  DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.

Authors:  Lotte Coelmont; Xavier Hanoulle; Udayan Chatterji; Carola Berger; Joke Snoeck; Michael Bobardt; Precious Lim; Inge Vliegen; Jan Paeshuyse; Grégoire Vuagniaux; Anne-Mieke Vandamme; Ralf Bartenschlager; Philippe Gallay; Guy Lippens; Johan Neyts
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

Review 9.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  A comparative analysis of the fluorescence properties of the wild-type and active site mutants of the hepatitis C virus autoprotease NS2-3.

Authors:  Toshana L Foster; Philip R Tedbury; Arwen R Pearson; Mark Harris
Journal:  Biochim Biophys Acta       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.